Preventative Botox: Best Age, Baby Botox and the Evidence

Preventative Botox is a botulinum toxin injection given to relax expression muscles before lines become etched into the skin at rest, rather than to soften lines that are already there. The American Society of Plastic Surgeons describes it as using neuromodulators early, before etched-in lines become deeply established at rest. A 2025 systematic review places it within prejuvenation, a blend of prevention and rejuvenation in which people seek early treatment to prevent aging rather than reverse it, sometimes asking for a neurotoxin before any visible lines appear.

The distinction that matters is between dynamic and static lines. Dynamic lines appear only when a muscle contracts, such as the vertical lines between the brows when you frown, and they disappear when your face relaxes. Static lines stay visible at rest. The American Academy of Dermatology explains that when you repeatedly contract the same muscles for many years, those lines become permanent. Preventative treatment aims at the gap between the two.

Botulinum toxin blocks the nerve signal that tells an injected muscle to contract, so the crease that muscle folds into the skin forms less often and less deeply while the dose lasts. For frown lines, the Botox Cosmetic label puts that effect at about three to four months. Because it is temporary, any preventative benefit depends on repeating it.

Preventative Botox is not a separate product or an FDA category. It is the same prescription drug given earlier, often at lower doses, to people with faint or no resting lines. That detail matters for how the product label applies, which section 4 covers.

Preventative Botox may slow the etching of lines in the muscles that are treated, but the evidence is limited to a single case report, short trials in people who already had lines, and a systematic review that calls the data heterogeneous. We found no study that started treatment in young adults with no lines and followed them for years against an untreated group.

The study most often quoted is a 2006 case report by William Binder in Archives of Facial Plastic Surgery. One identical twin had Botox in the forehead and frown area about two to three times a year for 13 years; her sister had it only twice. The regularly treated twin had no forehead or frown lines at rest, while her minimally treated sister did. Untreated areas, such as the folds running from nose to mouth, looked equally aged in both.

That is a comparison of two people, documented in photographs by the physician who treated them. It is suggestive, but it cannot tell you how often the result would repeat, which dose matters, or whether starting in your 20s adds anything over starting later.

Controlled trials answer a narrower question. In pooled data from two placebo-controlled trials, 183 people with mild frown lines at rest received a standard 20 unit dose; at 30 days, 68 percent had those resting lines erased, and the advantage over placebo was smaller, though still significant, by day 120. A later Allergan-sponsored study gave 225 adults three treatments four months apart and found resting lines improved progressively across cycles. Both enrolled people whose lines were already visible at rest, so they show treatment of early static lines rather than prevention from scratch.

The table below sets out what each piece of evidence actually tested. Read the last column as carefully as the third.

Baby Botox and micro Botox are different techniques that are often confused. Baby Botox is a lower total dose injected into the same muscles as a standard treatment, for a lighter effect. Micro Botox, also called microbotox, mesobotox or the microdroplet technique, places many tiny droplets of diluted toxin into the skin itself rather than deep into the muscle.

Baby Botox is a clinic term, not a defined or labeled dose. NPR describes clinics marketing it as lower dose treatments given less often than those for midlife adults. The idea is a lighter effect that keeps more expression, and the trade-off is duration. In a dose ranging trial of frown lines, 83 percent of people given 10 units had relapsed by four months, against 28 to 33 percent of those given 20 to 40 units. That trial enrolled women with moderate to severe lines, so it is a guide to direction rather than a prediction for a younger face.

Micro Botox works on the skin more than on expression. A 2022 review describes it as multiple microdroplets placed in the intradermal plane, acting on the superficial muscle fibers that attach to the underside of the skin while sparing the deeper ones, with the potential to reduce sweat and oil gland activity and improve texture. The same review calls it a common off-label use and notes that knowledge about dilution, volume and injection depth remains scarce. The Botox Cosmetic label specifies intramuscular injection, so an intradermal technique is off-label in route as well as purpose.

The best summary of micro Botox evidence is a 2024 systematic review and meta-analysis. Ten studies with 153 participants reported improvements in oil production, pore size, redness, fine wrinkles and texture, but not in skin hydration, and none reached the sample size needed for a firm conclusion. It is a skin quality treatment with early evidence, not a proven way to prevent expression lines.

Neither technique is a filler. If what you actually want is a subtle change in shape or fullness, that is a different treatment conversation, such as a mini lip plump with filler, rather than a neurotoxin one.

In most cases, yes. The Botox Cosmetic label covers adult patients and four specific uses: temporary improvement of moderate to severe frown lines, crow's feet, forehead lines and platysma bands. Faint lines, or lines that have not formed yet, fall outside that wording.

The same pattern holds across brands. The cosmetic indications on the Dysport, Xeomin, Jeuveau, Daxxify and Letybo labels each name moderate to severe lines in adults, and Dysport's is further limited to adults younger than 65. Our comparison of Botox, Dysport, Daxxify and Letybo sets the brands side by side.

Off-label means the FDA has not reviewed evidence for that particular use, so the trial results in the label do not describe your situation. Your prescriber makes that judgment, which is why it is fair to ask what evidence they are relying on. The Botox Cosmetic label adds two points worth knowing: dosing more often than every three months has not been clinically evaluated, and units of one brand cannot be compared to or converted into units of another.

The label also warns that serious adverse reactions, including excessive weakness and swallowing problems, have been reported after unapproved uses of BOTOX, and that safety and effectiveness for unapproved uses have not been established. In several of those reports, patients already had swallowing difficulty or other significant disabilities.

There is no evidence-based best age. The only firm floor is 18: each of the six cosmetic neurotoxin labels we checked is written for adults, and the Botox Cosmetic label states that safety and effectiveness have not been established in pediatric patients. Beyond that, the American Society of Plastic Surgeons frames the question as what your face is doing rather than how old it is.

A simple way to read your own face is to make the expression and then relax. If the line vanishes completely at rest, it is dynamic and nothing is etched yet. If a faint line stays when you relax, especially between the brows or across the forehead, that is the early resting line the controlled studies above actually treated. Deep folds and jowls are a different problem that a neurotoxin does not address.

Starting at 25 rather than 35 means more treatments over a lifetime, and that has costs beyond money. The Botox Cosmetic label notes that, as a therapeutic protein, the drug has a potential to provoke antibodies. A surgeon quoted by the American Society of Plastic Surgeons warns that you may develop resistance over time and that prolonged paralysis can make a muscle thin. The 2025 systematic review lists progressive tolerance, neuromuscular adaptation and long-term structural change as open questions that need longitudinal study. We found no study that has measured these outcomes in people who started in their 20s.

Where the toxin is placed decides what happens to your brow, and a small dose does not remove that risk. The forehead shows why. The frontalis is the only muscle that lifts the eyebrows. The corrugator, procerus, depressor supercilii and the orbicularis oculi around the eye pull the brow down. Eyebrow position is a balance between those two sets of forces.

Brow drop comes from weakening the frontalis too much or too close to the brow, which leaves the depressors pulling unopposed. Relaxing the depressors does the opposite: it eases the downward pull on the brow. The Botox Cosmetic label pairs forehead line treatment with frown line treatment to minimize the potential for brow ptosis, and in the forehead line trials 2 percent of treated people had brow ptosis.

So a forehead-only dose deserves a careful conversation, however small it is. Injecting the frontalis too low is a recognized cause of brow ptosis: one technique paper describes keeping forehead injections well above the bony rim of the eye socket as the established way to prevent it. Our guide to Botox for forehead lines explains how the forehead and frown areas are planned together.

Eyelid droop is a separate complication. To reduce it, the label's technique section tells injectors to avoid injecting near the levator palpebrae superioris, the small muscle that lifts the upper eyelid. Eyelid ptosis was the most common adverse reaction in the frown line trials, at 3 percent. The eye area calls for the same care in crow's feet treatment.

Preventative Botox costs the per unit or per area price, multiplied by the units used, multiplied by the number of visits you keep up each year. We do not quote a national figure, because prices vary between practices, and our guide to Botox pricing per unit versus per area explains how to compare quotes fairly.

A lower dose costs less per visit. It does not necessarily cost less per year. In the dose ranging trial described in section 3, the lowest dose wore off sooner than the others, so a lighter dose can mean the same number of visits, or more, to keep the effect going.

Our guide to how many units of Botox you need shows what a typical plan involves by area, and our guide on how often to get Botox covers realistic intervals. When you get a quote, ask for the brand, the number of units, the per unit price and the expected interval, then multiply it out across a year.

Prevention is also open-ended. As NPR's reporting puts it, if you stop the injections, the effects wear off and wrinkles reappear. Whatever you spend buys prevention only for as long as you keep treating.

Daily sunscreen has better evidence for preventing skin aging than preventative Botox does. In a randomized trial in Nambour, Australia, 903 adults younger than 55 were assigned to daily broad-spectrum sunscreen or to their usual discretionary use. After 4.5 years, the daily sunscreen group showed no detectable increase in skin aging, and aging from baseline was 24 percent less than in the discretionary group.

The American Academy of Dermatology recommends protecting your skin from the sun every day with sunscreen that is broad-spectrum, SPF 30 or higher and water-resistant, along with shade and sun-protective clothing. It also says smoking greatly speeds up how quickly skin ages and causes wrinkles, and that sunglasses can help reduce lines caused by squinting.

Topical retinoids work on the skin rather than the muscle. Prescription tretinoin cream 0.02 percent (Renova) is FDA-approved as an adjunct for mitigating fine facial wrinkles in people who also follow comprehensive skin care and sunlight avoidance, and its label states plainly that it does not eliminate wrinkles, repair sun damage or reverse photoaging. Tretinoin is a skin irritant, and oral tretinoin has caused birth defects in animal studies, so raise any pregnancy plans with the prescriber.

Sunscreen, retinoids and not smoking act on the skin itself, which a neurotoxin does not treat. A neurotoxin only addresses lines made by muscle movement. If you are deciding where to start, sunscreen is the step with randomized evidence behind it.

Some people should not have it at all, and others need a careful medical conversation first. The Botox Cosmetic label is the reference point for each group below.

Anyone under 18 is outside the label, which states that safety and effectiveness have not been established in pediatric patients. In pregnancy, the label reports no studies or adequate data on developmental risk, and animal studies showed effects on fetal growth at doses associated with maternal toxicity. For breastfeeding, there are no data on whether the drug appears in milk or affects the child. Because preventative treatment is elective, those gaps are a reasonable reason to postpone, and a question to raise with your prescriber.

People with neuromuscular disorders face higher risk. The label names peripheral motor neuropathic diseases, amyotrophic lateral sclerosis and neuromuscular junction disorders such as myasthenia gravis or Lambert-Eaton syndrome, where treatment may cause clinically significant effects including generalized weakness, double vision, drooping, and swallowing or breathing problems. The drug is contraindicated with a known allergy to any botulinum toxin product or its components, and with infection at the planned injection site. Existing swallowing or breathing difficulties also call for caution.

Our guide to whether Botox is safe covers the full list of side effects. And if the wish to prevent aging feels urgent or distressing, a researcher interviewed by NPR noted that patients with body dysmorphic disorder or severe depression are better treated by a mental health professional than by a cosmetic procedure.

A good consultation for preventative treatment should end with a plan you can check, not a vague promise. Bring the questions below, and use our guide on how to talk to your injector for help framing what you want.

Which of my lines do you see at rest, and which only with movement? Which brand, how many units, into which muscles, and why that dose for my face? Is this within the product's labeled use, and if not, what evidence are you relying on? If you treat my forehead, how will you protect my brow position? How long should I expect this dose to last, and what will a year of treatment cost at that interval? What would you advise if I only used daily sunscreen for now?

Also confirm who will inject you and what license they hold. The rules differ by state, and our guide on who can inject Botox in each state sets them out from the statutes and board rules.